• SENSEX 76,295.36
    -322.08 (--0.42%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)

IPO

Explore our secure online trading, IPO bidding, mutual fund investments, and depository services, all designed to provide seamless transactions, expert insights, and real-time market access for smart investing

Asston Pharmaceuticals Ltd

Asston Pharmaceuticals Ltd

    Registered Office : 4th Flr Office No.A-431 Balaji,Bhavan Plot No.42A Sec-11 CBD,Mumbai Maharashtra 400614 Phone : +91 22 4973 1411/+91 22 4973 1419
    Fax :

    Email : info@asstonpharmaceuticals.com

    Website : www.asstonpharmaceuticals.com

Initial public issue of up to 22,41,600 equity shares of face value of Rs.10/- each (the "Equity Shares") of Asston Pharmaceuticals Limited ("the Company" or "APL" or "the Issuer") at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores ("Public Isue") out of which upto 1,12,800 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of upto 21,28,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating upto Rs. [*] crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute [*] % and [*] %, respectively of the post-issue paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.

Issue

Opens On

Closes On

01-Jan-1970

01-Jan-1970

Money Payable On

Application

Allotment

0.00

0.00

Minimum Application for shares in Nos : 0.0 Further Multiples of : 0.0

₹Cr

Lead Managers to the Issue

Project Cost (₹.Cr)

Project Financed through Current Offer (₹.Cr)

Post Issue Equity Share Capital (₹.Cr)

Issue Price (₹.Cr)

0.00

0.00

8.51

0.00

Sobhagya Capital Options Pvt. Ltd.

Projects
  • Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
  • Funding the incremental working capital requirements of our company
  • Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our company.
  • General corporate purposes
Promoted By
  • Ashish Narayan Sakalkar
  • Saili Jayaram More
  • Sachin Chandrakant Badakh
Listing At
  • BSE - SME
Registrar to the Issue
  • Maashitla Securities Pvt Ltd